Company Intelligence

Cellbyte

Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders…

Official Website
In this profile

Quick Facts

  • Founded 2022
  • Headquarters Munich, Germany
  • Country Germany
  • Industry AI in Healthcare
  • Company Type Early
  • Status Active
  • Website Official site
  • Last Reviewed Jul 2026

Executive Summary

Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.

The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.

Why It Matters

AI Agents for Pharma Drug Launches

Recent Developments

  1. 2022 Company founded

    Cellbyte was founded in 2022 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

AI in Healthcare Open industry

Cellbyte’s AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.

The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Request a correction if you represent this company or believe information is inaccurate.

Explore Related Intelligence

Products Product directory Founders Founder profiles Reports Open reports Industries Explore sectors

The AI Brief

Weekly company intelligence in your inbox.

Subscribe